Home > Health > View from the Top

More Action Necessary to Tackle Silent Killer

Corrado de Gennaro - Galderma
General Manager for Mexico and North Cone Latam

STORY INLINE POST

Wed, 09/05/2018 - 13:01

share it

Q: What areas is Galderma prioritizing in Mexico?

A: As an emerging market with a large population and low penetration in dermatology, Mexico is very attractive to Galderma. Over the last few years, Galderma has grown in double digits and above the market in most of the categories where it competes, a clear indicator of how wellreceived our products are in the country. Galderma has a strong presence in acne, rosacea, atopic dermatitis and psoriasis. We also play in the growing aesthetic field with a complete portfolio of fillers, bio-stimulants and toxins.

Q: What are Galderma’s strongest products in Mexico?

A: Galderma has three divisions: prescription, selfmedication and aesthetics. We have a predominant market position in the treatment of acne, rosacea, atopic dermatitis and dermo-cosmetic cleansing and moisturizing products, as well as facial injectables, including neurotoxins and hyaluronic acid.

Q: Which new products will Galderma launch in 2018?

A: We are expanding our presence in the sun-care category, launching Cetaphil Sun and a Sculptra, a polylactic acid, an injectable bio-stimulator of collagen. The latter is one of the most innovative products in the market.

You May Like

Most popular

Newsletter